欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号HU/H/0890/003
药品名称Nilotinib Viatris 200 mg hard capsule
活性成分
    • Nilotinib 200.0 mg
剂型Capsule, hard
上市许可持有人Viatris Ltd Damastown Industrial Park Mulhuddart, Dublin 15 Dublin, Ireland E-mail: mylanireland.mahs@viatris.com
参考成员国 - 产品名称Hungary (HU)
互认成员国 - 产品名称
    • Netherlands (NL)
      Nilotinib Viatris 200 mg, harde capsules
    • Estonia (EE)
    • Luxembourg (LU)
    • Bulgaria (BG)
      Nilotinib Viatris
    • Iceland (IS)
    • Cyprus (CY)
      Nilotinib/Viatris Capsules hard, 200 mg/cap
    • Austria (AT)
    • Czech Republic (CZ)
      Nilotinib Viatris
    • France (FR)
    • Slovak Republic (SK)
    • Portugal (PT)
    • Malta (MT)
    • Italy (IT)
    • Greece (EL)
    • Norway (NO)
    • Germany (DE)
      Nilotinib Viatris Hartkapseln 200 mg
    • Poland (PL)
      Nilotinib Viatris
    • Denmark (DK)
      Nilotinib Viatris
    • Latvia (LV)
    • Belgium (BE)
    • Lithuania (LT)
      Nilotinib Viatris 200 mg kietosios kapsulės
许可日期2024/05/28
最近更新日期2025/12/12
药物ATC编码
    • L01EA03 nilotinib
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase